Verdenssamfundets vedtagne sandheder falder i hastigt tempo fra hinanden, institutionerne er i opløsning, klimaet rækker ind i alt, og politiske slagord trumfer vores love. To gange om ugen undersøger vært Kaspar Colling Nielsen bevægelserne bag tidens største nyhedshistorier.
…
continue reading
Content provided by DR. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DR or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Allergisæsonen er over os: ALK's CEO Peter Halling i studiet
MP3•Episode home
Manage episode 426290378 series 3292492
Content provided by DR. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DR or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
ALK-Abellós CEO er inviteret i studiet til en snak om allergimedicin. Med en halv milliard allergigere globalt er der et enormt potentiale for ALK, der i dag har 2,5 millioner kunder. Med et glas 1'er Cru fra Bourgogne i glasset går snakken om ALK's strategi, investeringscasen og pipelinen, der blandt andet rummer medicin mod peanuts-allergi. Oskar vinder sæsonen med en flot stigning på 40% i Zealand Pharma, mens Jakob forsøger at få et sommerpoint med en investering i sydkoreansk gaming.
…
continue reading
73 episodes
MP3•Episode home
Manage episode 426290378 series 3292492
Content provided by DR. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DR or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
ALK-Abellós CEO er inviteret i studiet til en snak om allergimedicin. Med en halv milliard allergigere globalt er der et enormt potentiale for ALK, der i dag har 2,5 millioner kunder. Med et glas 1'er Cru fra Bourgogne i glasset går snakken om ALK's strategi, investeringscasen og pipelinen, der blandt andet rummer medicin mod peanuts-allergi. Oskar vinder sæsonen med en flot stigning på 40% i Zealand Pharma, mens Jakob forsøger at få et sommerpoint med en investering i sydkoreansk gaming.
…
continue reading
73 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.